Science · LNP Biology

Lipid nanoparticle structure, self-assembly, and endosomal escape

A mechanistic look at how ionizable lipids, PEG-lipids, cholesterol, and helper lipids cooperate to encapsulate mRNA and release it into the cytoplasm.

Cutaway diagram of a lipid nanoparticle showing ionizable lipid core, PEG-lipid corona, mRNA payload, and cholesterol helper lipid bilayer

LNP cross-section: ionizable lipid core (cyan), PEG-lipid corona (teal), mRNA payload (amber), cholesterol (white dots)

Anatomy

The four-component LNP

Every LNP formulation is a balance of four excipients, each with a distinct function.

Ionizable Lipid

The functional core: neutral at physiological pH (7.4), protonated in the endosome (pH 5.0–6.5). Protonation drives membrane fusion and mRNA release. pKa range 6.2–6.8 is optimal.

Helper Lipid

DSPC, DOPE, or DPPC stabilize the bilayer structure and modulate membrane fluidity. DOPE's cone shape facilitates hexagonal phase transition during endosomal escape.

Cholesterol

Increases membrane rigidity, affects particle size and PDI. Regulates membrane fusion propensity. Typical range 35–45 mol%.

PEG-Lipid

Steric stabilization prevents aggregation and opsonization. PEG density (0.5–3.5 mol%) trades off serum stability against endosomal escape rate.

The pKa Dial

Why pKa 6.2–6.8 is the sweet spot

An ionizable lipid with apparent pKa < 6.0 is insufficiently protonated at endosomal pH, producing weak membrane disruption and low mRNA release. Above pKa 7.0, the lipid carries positive charge at physiological pH — which promotes non-specific protein binding and clearance by phagocytes before the particle reaches the hepatocyte.

The therapeutic window is narrow. Gendelivr's in silico pKa model predicts apparent pKa within ±0.15 units across a library of 1,200 ionizable lipid structures.

Apparent pKa and Activity

pKa 5.8
6.5
7.2
Low pKa (<6.0)
Weak escape
Optimal (6.2–6.8)
Peak transfection
High pKa (>7.0)
Toxicity/clearance
Continue Reading

More science from Gendelivr

CRISPR-Cas9 Delivery

Why LNP-mediated mRNA CRISPR delivery outperforms viral vectors for in-vivo hepatic editing.

Read

Hepatic Targeting

ApoE-mediated endocytosis and the hepatocyte targeting mechanism behind LNP organ selectivity.

Read

Formulation Engine

See how Gendelivr applies this biology to screen 10,000 formulations in silico before bench synthesis.

Explore